Cutaneous Involvement in Erythroleukemia

Shaklai, Mati; M, Nir; Feuerman, E; Pinkhas, J; Vries, A. De

doi:10.1159/000251547

Dermatology

1974

DOI: 10.1159/000251547

|View full text |Cite

Cutaneous Involvement in Erythroleukemia

Mati Shaklai¹,

Nir M²,

E Feuerman³

et al.

Abstract: A rapidly necrotizing leukemic skin infiltrate appeared simultaneously with a fatal blastic crisis in a patient with chronic erythroleukemia. Local X-ray irradiation and systemic cytotoxic, antibiotic and corticosteroid treatment were of no avail.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1975

1979

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Letter: Metoclopramide and facial dyskinesia.

Melmed¹,

Bank²

1975

BMJ

View full text Add to dashboard Cite

is poor and on the verge of disintegration. The key figures in the service, the consultants, are being treated like serfs and the whole setup is reminiscent of a sinking ship. Moreover, the salary for tihese proposed coordinators was to be a consultant's starting salary. How could one offer less? A first-year full-time consultant like myself would find that the nine-to-five office worker was drawing the same salary with no clinical responsibility and the vaguest of notions of job description. Many of the applicants did not even know what the job enitailed. One

show abstract

Letter: Metoclopramide and facial dyskinesia.

Melmed¹,

Bank²

1975

BMJ

View full text Add to dashboard Cite

show abstract

Newer Aspects of Preleukemic Disorders

Kass

Penner

1979

CRC Critical Reviews in Clinical Laboratory Sciences

View full text Add to dashboard Cite

Preleukemic disorders are a controversial group of panmyelopathic disturbances that often precede the emergence of acute myeloblastic or myelomonocytic leukemia. In most instances, these preleukemic disorders are characterized by slowly developing myeloblastosis of the bone marrow. They include preleukemia, primary acquired panmyelopathy with myeloblastosis or smouldering acute leukemia, erythroleukemia, and subacute myelomonocytic leukemia. Sometimes, transitions between these various preleukemic disorders may be observed in a single individual. Abnormalities in cellular differentiation are expressed in cytochemical aberrations and in elaboration of colony forming units by marrow cells of patients with preleukemic disorders. Cytogenic and cellular kinetic abnormalities link preleukemic disorders closely to acute myeloblastic or myelomonocytic leukemia, although in many patients with preleukemic disorders, conversion to acute leukemia is not observed or perhaps not recognized. Understanding pathogenetic and pathophysiological aspects of preleukemic disorders may shed light on aspects of cellular proliferation and cellular differentiation in the acute leukemias.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cutaneous Involvement in Erythroleukemia

Abstract: A rapidly necrotizing leukemic skin infiltrate appeared simultaneously with a fatal blastic crisis in a patient with chronic erythroleukemia. Local X-ray irradiation and systemic cytotoxic, antibiotic and corticosteroid treatment were of no avail.

Cited by 2 publications

References 2 publications

Letter: Metoclopramide and facial dyskinesia.

Letter: Metoclopramide and facial dyskinesia.

Newer Aspects of Preleukemic Disorders

Contact Info

Product

Resources

About